City of Hope

www.cityofhope.org

 

City of Hope
M

2019 ESMO Update: Phase 1 Study of AMG 510, a Novel KRAS G12C Inhibitor in Advanced Solid Tumors w/KRAS G12C Mutation

By City of Hope FEATURING Marwan G. Fakih
By City of Hope FEATURING Marwan G. Fakih
423 views
November 29, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
General Oncology
13:16
Total Health

Universal Comprehensive Genomic Profiling and Treatment Planning

Feat. R. Salgia
17:50
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

Breast/Ovarian Cancer Genetic Risk Assessment: BRCA1/2, PALB2 & …

Feat. J. Weitzel
12:31
City of Hope

2019 ESMO Update: Phase 1 Study of AMG 510, a Novel KRAS G12C Inhibi…

Feat. M. Fakih